Skip to main content
SAMJIN PHARMACEUTICAL CO.,LTD logo

SAMJIN PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 005500 ISIN · KR7005500004 KO Manufacturing
Open in API
Filings indexed 253 across all filing types
Latest filing 2021-04-26 Director's Dealing
Country KR South Korea
Listing KO 005500

About SAMJIN PHARMACEUTICAL CO.,LTD

https://www.samjinpharm.co.kr/

Samjin Pharmaceutical Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of medicines. The company's portfolio includes a wide range of over-the-counter (OTC) and prescription drugs, offered in various formulations such as oral, drop, and injectable forms. Notable products include the analgesic Gevorin, the antiplatelet agent Plavix, and the hypercholesterolemia treatment Newstatin-R. A central part of its strategy is a strong commitment to R&D, focusing on creating innovative new drugs to address diseases with high unmet medical needs. The company actively develops novel therapeutics for severe conditions, including cardiovascular, respiratory, and gastrointestinal diseases, with the goal of becoming a global pharmaceutical innovator.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the shareholding changes of an executive (Cho Kyu Seok) at Samjin Pharmaceutical. This type of filing is specifically categorized as 'Director's Dealing' (DIRS) in the provided schema, as it reports personal share transactions by company executives.
2021-04-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities (Financial Supervisory Service/KRX). It details the shareholding changes of a specific executive (Cho Kyu Hyung) of Samjin Pharmaceutical. This type of filing is a standard regulatory disclosure for insider holdings, which falls under the 'Director's Dealing' category in the provided schema.
2021-04-26 Korean
신규시설투자등
Capital/Financing Update Classification · 98% confidence The document is a regulatory disclosure from Samjin Pharmaceutical regarding a 'New Facility Investment' (신규시설투자등). It details the investment amount, purpose (EU-GMP injection line construction), and timeline. This type of disclosure regarding capital expenditure and facility expansion is classified as a general regulatory filing under the RNS category as it does not fit into specific categories like M&A, share issuance, or financial reports.
2021-04-07 Korean
[기재정정]신규시설투자등
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Samjin Pharmaceutical regarding a 'Correction Report' (정정신고) for a 'New Facility Investment' (신규시설투자). It details changes to investment amounts and timelines for a new research center. Since this is a specific regulatory disclosure regarding capital expenditure and facility investment, it falls under the 'Regulatory Filings' category as it does not fit into more specific categories like M&A, Share Issues, or Dividends.
2021-04-07 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (정기주주총회결과). It details the outcomes of agenda items such as financial statement approval, dividend declarations, and the election of directors. This falls directly under the category of Declaration of Voting Results & Voting Rights Announcements.
2021-03-26 Korean
대표이사(대표집행임원)변경(안내공시)
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the change of Representative Directors (CEO/Executive Officers) at Samjin Pharmaceutical. It lists the names of the outgoing and incoming directors, the reason for the change (term expiration), and the effective date. This falls directly under the definition of Board/Management Information (MANG).
2021-03-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.